The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2023

Filed:

May. 11, 2020
Applicant:

The Scripps Research Institute, La Jolla, CA (US);

Inventors:

Jie Li, San Diego, CA (US);

Zilei Liu, San Diego, CA (US);

Suhua Li, Guangzhou, CN;

Peng Wu, San Diego, CA (US);

K. Barry Sharpless, La Jolla, CA (US);

Assignee:

THE SCRIPPS RESEARCH INSTITUTE, La Jolla, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61K 31/136 (2006.01); C07C 305/26 (2006.01); C07K 1/113 (2006.01); C07K 1/02 (2006.01); A61K 51/04 (2006.01); A61K 38/31 (2006.01); A61K 31/7048 (2006.01); A61K 31/70 (2006.01); A61K 31/655 (2006.01); A61K 31/65 (2006.01); A61K 31/56 (2006.01); A61K 31/5513 (2006.01); A61K 31/53 (2006.01); A61K 31/515 (2006.01); A61K 31/505 (2006.01); A61K 31/485 (2006.01); A61K 31/4745 (2006.01); A61K 31/473 (2006.01); A61K 31/4709 (2006.01); A61K 31/47 (2006.01); A61K 31/439 (2006.01); A61K 31/4353 (2006.01); A61K 31/4245 (2006.01); A61K 31/4168 (2006.01); A61K 31/407 (2006.01); A61K 31/4045 (2006.01); A61K 31/40 (2006.01); A61K 31/397 (2006.01); A61K 31/198 (2006.01); A61K 31/197 (2006.01); A61K 31/14 (2006.01); C07K 2/00 (2006.01); C07D 295/26 (2006.01); C07D 295/185 (2006.01); C07D 295/088 (2006.01); C07D 277/82 (2006.01); A61K 47/54 (2017.01); C40B 30/06 (2006.01); C40B 30/04 (2006.01); C40B 50/08 (2006.01); C12N 5/09 (2010.01); C40B 40/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/136 (2013.01); A61K 31/14 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/407 (2013.01); A61K 31/4045 (2013.01); A61K 31/4168 (2013.01); A61K 31/4245 (2013.01); A61K 31/439 (2013.01); A61K 31/4353 (2013.01); A61K 31/47 (2013.01); A61K 31/473 (2013.01); A61K 31/4709 (2013.01); A61K 31/4745 (2013.01); A61K 31/485 (2013.01); A61K 31/505 (2013.01); A61K 31/515 (2013.01); A61K 31/53 (2013.01); A61K 31/5513 (2013.01); A61K 31/56 (2013.01); A61K 31/65 (2013.01); A61K 31/655 (2013.01); A61K 31/70 (2013.01); A61K 31/7048 (2013.01); A61K 38/31 (2013.01); A61K 47/54 (2017.08); A61K 51/0497 (2013.01); C07C 305/26 (2013.01); C07D 277/82 (2013.01); C07D 295/088 (2013.01); C07D 295/185 (2013.01); C07D 295/26 (2013.01); C07K 1/02 (2013.01); C07K 1/1136 (2013.01); C07K 2/00 (2013.01); C40B 30/06 (2013.01); C07C 2601/14 (2017.05); C07C 2603/18 (2017.05); C12N 5/0693 (2013.01); C12N 2503/02 (2013.01); C40B 30/04 (2013.01); C40B 40/04 (2013.01); C40B 50/08 (2013.01); G01N 2500/00 (2013.01);
Abstract

A high-throughput screening methods for identifying candidate anticancer medicinal agents is described herein. The candidate anticancer medicinal agents are arylfluorosulfate compounds derived from phenolic compounds. The method involves in situ generation of the arylfluorosulfate compounds in multi-well plates by reaction of phenolic compounds in DMSO with a saturated solution of SOFdissolved in a solvent such as acetonitrile, in the presence of an organic base, followed by reaction of generated fluoride ion with trimethylsilanol to form volatile trimethylsilyl fluoride. Solvents, organic base, and silyl compounds are then removed, in vacuo, to afford the arylfluorosulfate compounds suitable for biological screening in cancer cell lines without further purification.


Find Patent Forward Citations

Loading…